These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 23722570)

  • 1. The classification and application of toxic Chinese materia medica.
    Liu X; Wang Q; Song G; Zhang G; Ye Z; Williamson EM
    Phytother Res; 2014 Mar; 28(3):334-47. PubMed ID: 23722570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current situation of toxicity classification of Chinese materia medica and its research thoughts].
    Sun W; Hou X; Wang B; Zhu Y; Zhang S; Chang H; Sun J
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2199-201. PubMed ID: 23189717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional toxicity documentation of Chinese Materia Medica--an overview.
    Leung AY
    Toxicol Pathol; 2006; 34(4):319-26. PubMed ID: 16787890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality and safety of Chinese herbal medicines guided by a systems biology perspective.
    Wang J; van der Heijden R; Spruit S; Hankermeier T; Chan K; van der Greef J; Xu G; Wang M
    J Ethnopharmacol; 2009 Oct; 126(1):31-41. PubMed ID: 19683045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Toxicity and Attenuation Methods of Toxic Chinese Materia Medica for its Reasonable Application: A Review.
    Xiang JY; Chi YY; Han JX; Xiang H; Xie Q
    Am J Chin Med; 2021; 49(1):41-67. PubMed ID: 33416023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China.
    Williamson EM; Lorenc A; Booker A; Robinson N
    J Ethnopharmacol; 2013 Sep; 149(2):453-62. PubMed ID: 23832055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique issue in the standardization of Chinese materia medica: processing.
    Zhao Z; Liang Z; Chan K; Lu G; Lee EL; Chen H; Li L
    Planta Med; 2010 Dec; 76(17):1975-86. PubMed ID: 21049396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles for molecular identification of traditional Chinese materia medica using DNA barcoding].
    Chen SL; Yao H; Han JP; Xin TY; Pang XH; Shi LC; Luo K; Song JY; Hou DY; Shi SM; Qian ZZ
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):141-8. PubMed ID: 23672031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review on Processing Methods of Toxic Chinese Materia Medica and the Related Mechanisms of Action.
    Pan L; Wang Y; Yue L; Wang N; Xu W; Liao X; Wang H; Xiu Y
    Am J Chin Med; 2023; 51(6):1385-1412. PubMed ID: 37545180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the traditional aspect of Chinese medicine in order to achieve meaningful quality control of Chinese materia medica.
    Xie PS; Leung AY
    J Chromatogr A; 2009 Mar; 1216(11):1933-40. PubMed ID: 18757061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction of biopharmaceutics classification system of Chinese materia medica].
    Liu Y; Wei L; Dong L; Zhu ML; Tang MM; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4479-83. PubMed ID: 25911786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in research into the mechanisms of Chinese Materia Medica against acute lung injury.
    Ding Z; Zhong R; Xia T; Yang Y; Xing N; Wang W; Wang Y; Yang B; Sun X; Shu Z
    Biomed Pharmacother; 2020 Feb; 122():109706. PubMed ID: 31918277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination system for prediction of Chinese Materia Medica properties.
    Long W; Liu P; Xiang J; Pi X; Zhang J; Zou Z
    Comput Methods Programs Biomed; 2011 Mar; 101(3):253-64. PubMed ID: 21315471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Integration of Chinese Material Medica into the Chinese Health Care Delivery System, an Update.
    Dang H; Wang Q; Wang H; Yan M; Liu X
    Phytother Res; 2016 Feb; 30(2):292-7. PubMed ID: 26728426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strategies for efficacy and function positioning of new resources of Chinese materia medica].
    Li ZY; Wang JQ; Li CF; Zhang XB; Yang HJ; Huang LQ; Yang B
    Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(14):3455-3464. PubMed ID: 34402267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of asthma using the Chinese Materia Medica.
    Liu JX; Zhang Y; Yuan HY; Liang J
    J Ethnopharmacol; 2021 Apr; 269():113558. PubMed ID: 33186702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substance basis research on Chinese materia medica is one of key scientific problems of inheriting, development and innovation of Chinese materia medica].
    Yang XW
    Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3429-34. PubMed ID: 26978985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of historical changes in traditional Chinese medicine based on an Indonesian collection of Chinese materia medica from c. 1870.
    Jia Y; Lei L; Luo X; Zhao Z; Wang M; van Andel T
    J Ethnopharmacol; 2021 Apr; 269():113714. PubMed ID: 33352236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features and development trends in international standardization of Chinese materia medica in ISO/TC 249.
    Xu XT; Shi YH; Sang Z; Zhou H
    Pharmacol Res; 2021 May; 167():105519. PubMed ID: 33636352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research and development thought on biopharmaceutics classification system of Chinese materia medica].
    Liu Y; Wang ZY; Xu WJ; Zhang CJ; Dong L
    Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3637-3644. PubMed ID: 31602935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.